GCORE
6.6.2024 10:31:30 CEST | Business Wire | Press release
Gcore, the global edge AI, cloud, network, and security solutions provider, today announced the launch of Gcore Inference at the Edge, a breakthrough solution that provides ultra-low latency experiences for AI applications. This innovative solution enables the distributed deployment of pre-trained machine learning (ML) models to edge inference nodes, ensuring seamless, real-time inference.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240606719181/en/
Gcore Inference at the Edge empowers businesses across diverse industries with cost-effective, scalable, and secure AI model deployment (Graphic: Gcore)
Gcore Inference at the Edge empowers businesses across diverse industries—including automotive, manufacturing, retail, and technology—with cost-effective, scalable, and secure AI model deployment. Use cases such as generative AI, object recognition, real-time behavioural analysis, virtual assistants, and production monitoring can now be rapidly realised on a global scale.
Gcore Inference at the Edge runs on Gcore's extensive global network of 180+ edge nodes, all interconnected by Gcore's sophisticated low-latency smart routing technology. Each high-performance node sits at the edge of the Gcore network, strategically placing servers close to end users. Inference at the Edge runs on NVIDIA L40S GPUs, the market-leading chip designed specifically for AI inference. When a user sends a request, an edge node determines the route to the nearest available inference region with the lowest latency, achieving a typical response time of under 30 ms.
The new solution supports a wide range of fundamental ML and custom models. Available open-source foundation models in the Gcore ML Model Hub include LLaMA Pro 8B, Mistral 7B, and Stable-Diffusion XL. Models can be selected and trained agnostically to suit any use case, before distributing them globally to Gcore Inference at the Edge nodes. This addresses a significant challenge faced by development teams where AI models are typically run on the same servers they were trained on, resulting in poor performance.
Benefits of Gcore Inference at the Edge include:
- Cost-effective deployment: A flexible pricing structure ensures customers only pay for the resources they use.
- Inbuilt DDoS protection: ML endpoints are automatically protected from DDoS attacks through Gcore’s infrastructure.
- Outstanding data privacy and security: The solution features built-in compliance with GDPR, PCI DSS, and ISO/IEC 27001 standards.
- Model autoscaling: Autoscaling is available to handle load spikes, so a model is always ready to support peak demand and unexpected surges.
- Unlimited object storage: Scalable S3-compatible cloud storage that grows with evolving model needs.
Andre Reitenbach, CEO at Gcore comments: “Gcore Inference at the Edge empowers customers to focus on getting their machine learning models trained, rather than worrying about the costs, skills, and infrastructure required to deploy AI applications globally. At Gcore, we believe the edge is where the best performance and end-user experiences are achieved, and that is why we are continuously innovating to ensure every customer receives unparalleled scale and performance. Gcore Inference at the Edge delivers all the power with none of the headache, providing a modern, effective, and efficient AI inference experience.”
Learn more at https://gcore.com/inference-at-the-edge
About Gcore
Gcore is the global edge AI, cloud, network, and security solutions provider. Gcore provides its solutions to global leaders in numerous industries. The company manages its own global IT infrastructure across six continents, with one of the best network performances in Europe, Africa, and LATAM, due to the average response time of 30 ms worldwide. Gcore’s network consists of 180+ points of presence around the world in reliable Tier IV and Tier III data centres, with a total capacity exceeding 200 Tbps.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240606719181/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Cutting-Edge Research to Industry: Focused Energy Plans Spin-Off of Sourcelight10.6.2026 11:38:00 CEST | Press release
Following its successful USD 240 million financing round, Focused Energy is continuing to systematically advance the industrialization of laser fusion as its core business. At the same time, the company plans to consolidate its activities in the field of laser-driven radiation sources into an independent entity under the name Sourcelight. With this move, Focused Energy is laying the groundwork for the industrial transfer of selected technological building blocks emerging from its laser fusion development. The spin-off demonstrates how cutting-edge research can give rise to new industry: scientific excellence is translated into industrial applications with strong value creation and growth potential. Sourcelight is intended to bring the LDRS (Laser-Driven Radiation Sources) technology developed by Focused Energy into targeted industrial applications. The technology combines laser-driven high-energy X-rays and neutrons in a single system. This enables not only high-resolution imaging, but
Cosylab and Heron Neutron Medical Corp. Sign Letter of Intent to Advance Global Deployment of Accelerator-Based BNCT Systems10.6.2026 11:30:00 CEST | Press release
Cosylab and Heron Neutron Medical Corp. announced today, 10 June 2026, the signing of a Letter of Intent to establish a strategic framework for joint market development to support the global deployment of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) systems. The collaboration aims to accelerate the development and integration of sophisticated software solutions for use with AB-BNCT while strengthening AB-BNCT's international market access and business development. By combining Cosylab's proven expertise in mission-critical software and complex system integration with Heron's end-to-end BNCT platforms, the partnership aims to drive broader global clinical adoption of this highly targeted cancer treatment modality. "AB-BNCT is emerging as one of the most promising approaches for treating difficult-to-treat and recurrent cancers," said Mark Pleško, Chief Executive Officer of Cosylab. "This collaboration reinforces our strategic focus on advancing radiation therapy technologie
GlobalFoundries and Qualinx Demonstrate First European Sovereign Manufacturing Flow for Security‑Critical Semiconductors10.6.2026 11:25:00 CEST | Press release
First end-to-end European chip manufacturing flow proven for aerospace, defence, IoT, consumer electronics and critical infrastructure GlobalFoundries (GF) and Qualinx today announced the successful completion of the first fully European-based, end-to-end semiconductor manufacturing flow at GlobalFoundries’ Dresden fab on its FDX technology. The milestone demonstrates that security-critical chips for aerospace, defence and critical infrastructure can be designed, manufactured and delivered entirely within Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260610196220/en/ In this partnership, Qualinx served as the launch customer with a sophisticated GNSS SoC design for secure Positioning, Navigation and Timing (PNT) applications. The QLX3xx design targets sovereign GNSS-based PNT solutions for aerospace, defence and critical infrastructures—such as resilient timing and synchronization networks and highly integrated, ult
LTM Introduces BlueVerse™ Currency to Enable Outcome-Based Pricing in the Agentic AI Era10.6.2026 10:30:00 CEST | Press release
LTM, the Business Creativity partner to the world’s largest enterprises, today introduced BlueVerse™ Currency, an AI-linked commercial model that prices enterprise work by outcomes rather than effort consumed as enterprises scale agentic AI across core processes. BlueVerse Currency brings together the full BlueVerse stack—People (expertise on demand), Accelerators (reusable assets that speed delivery), Agents (autonomous AI workforce), Platforms (orchestration layer to scale delivery), and Tokens (compute and model usage)—into a single commercial construct. It introduces outcome-linked pricing tied to measurable business results, enabling shared productivity gains so clients can capture AI-driven efficiency value. The model also supports fungible resourcing, enabling reallocation mid-contract to evolving priorities, and faster reinvestment, with savings redirected into innovation. It is underpinned by a hybrid structure with fixed and variable pricing components, supported by use-case–
Smead Capital Management Extends International Value Strategy to Global Investors Through New Fund10.6.2026 09:00:00 CEST | Press release
Firm expands access to long-standing U.S.-based international strategy, bringing disciplined, value-driven investing to a broader global audience through the Smead Global ex-US Value UCITS Fund Smead Capital Management, a Phoenix-based investment management firm and a leader in value investing, today announced the launch of the Smead Global ex-US Value UCITS Fund designed to provide global investors with access to a product modeled after the firm’s long-standing Smead International Value Strategy. The Smead Global ex-US Value UCITS Fund is domiciled in Luxembourg. Investors can access the fund through Smead Capital Management’s website and it is available to professional and qualified investors through the fund’s transfer agent. The strategy that the Smead Global ex-US Value UCITS Fund is modeled after, the Smead International Value Strategy, has been a core contributor to Smead Capital Management’s outstanding performance for over a decade. Like all Smead products, the Global ex-US Va
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
